v3 Template
S

Sutro Biopharma, Inc.

Biotechnology ~460 employees
Founded
--
Employees (Est.)
~460
23 leaders known
Total Funding
$215.0M
Funding Rounds
2
Last Funding
2024-04-02

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development, and manufacturing, with a mission to transform cancer therapeutics through precisely designed solutions for improved patient outcomes.

Products & Services

iADCs & Antibody-Drug Conjugates:Innovative antibody-drug conjugates designed for targeted cancer therapy.
XpressCF+(r):A cell-free technology platform for developing therapeutics with potential for broader patient benefit.
cGMP Facility:A manufacturing facility adhering to current Good Manufacturing Practices for drug production.
STRO-004:A potential best-in-class Tissue Factor ADC, with a First-in-Human study planned for the second half of 2025.

Specialties

Cancer Therapeutics Antibody-Drug Conjugates (ADCs) Cell-Free Protein Synthesis (XpressCF) Oncology Drug Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Underwritten Offering
T: -
FT: Underwritten Offering
A: 75000000
MR: -
FA: $75 million
FAN: 75000000
D: 2024-04-02
FD: 2024-04-02
1 investors
2 RT: Royalty Financing
T: -
FT: Royalty Financing
A: 140000000
MR: -
FA: $140 million upfront
FAN: 140000000
D: 2023-06-26
FD: 2023-06-26
1 investors
Underwritten Offering Latest
2024-04-02
$75.0M
1 investor (Pro only)
Royalty Financing 2023-06-26
$140.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

L

Lawrence Fong

Member, Scientific Advisory Board

A

Anthony W. Tolcher

Member, Scientific Advisory Board

A

Ana Oaknin Benzaquen

Member, Clinical Advisory Board

R

R. Wendel Naumann

Member, Clinical Advisory Board

D

D. Ross Camidge

Member, Scientific Advisory Board

C

Carlos V. Paya

Chair, Scientific Advisory Board

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Sutro Biopharma, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~460 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro